Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1987;76:952-959

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ashton, J. H.
Right arrow Articles by Campbell, W. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ashton, J. H.
Right arrow Articles by Campbell, W. B.

Circulation, Vol 76, 952-959, Copyright © 1987 by American Heart Association


ARTICLES

Cooperative mediation by serotonin S2 and thromboxane A2/prostaglandin H2 receptor activation of cyclic flow variations in dogs with severe coronary artery stenoses

JH Ashton, ML Ogletree, IM Michel, P Golino, JM McNatt, AL Taylor, S Raheja, J Schmitz, LM Buja and WB Campbell
Department of Internal Medicine (Cardiology Division), University of Texas Health Science Center at Dallas 75235-9047.

We have reported previously that thromboxane A2/prostaglandin (PG)H2 and serotonin independently mediate the occurrence of cyclic flow variations (CFVs) in a canine preparation of severe coronary artery narrowing. This may be due to an effect of these substances on platelets and/or the vascular wall. We tested the hypothesis that there is a cooperative effect between thromboxane A2/PGH2 and serotonin receptor stimulation in the development of CFVs in this animal preparation. After placement of a hard plastic cylindrical constrictor around the left anterior descending coronary artery, CFVs develop and are characterized by repetitive cycles of declines in coronary blood flow and abrupt increases in flow. In a control group of dogs, CFV frequency (cycles/hour) and severity (lowest coronary blood flow just before its restoration) did not change significantly over a 3 hr interval. In a second group of dogs, CFVs were established after constrictor placement, abolished with the serotonin (5HT2) receptor antagonist ketanserin, and reestablished by the continuous infusion of serotonin into the left atrium. Serotonin-induced CFVs were then abolished with a thromboxane A2/PGH2 receptor antagonist, SQ29,548, or a thromboxane synthetase inhibitor, dazoxiben (UK37,248). The relative specificity of the respective antagonists, SQ29,548 and ketanserin, was determined in canine platelets and rat aortic vascular strips. No significant cross-reactivity between ketanserin and SQ29,548 was found. Thus, the data obtained in these studies demonstrate a cooperative interaction between thromboxane A2/PGH2 and serotonin S2 receptors that contributes to the development of CFVs in this experimental preparation.


This article has been cited by other articles:


Home page
Postgrad. Med. J.Home page
S U Shah, A White, S White, and W A Littler
Heart and mind: (1) relationship between cardiovascular and psychiatric conditions
Postgrad. Med. J., December 1, 2004; 80(950): 683 - 689.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. V. Anderson, J. McNatt, F. J. Clubb, M. Herman, J.-P. Maffrand, F. DeClerck, C. Ahn, L. M. Buja, and J. T. Willerson
Platelet Inhibition Reduces Cyclic Flow Variations and Neointimal Proliferation in Normal and Hypercholesterolemic-Atherosclerotic Canine Coronary Arteries
Circulation, November 6, 2001; 104(19): 2331 - 2337.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
D Tousoulis, C Tentolouris, T Crake, G Goumas, C Stefanadis, P Toutouzas, and G Davies
Complex stenosis morphology and vasomotor responses to inhibition of nitric oxide synthesis
Heart, November 1, 2000; 84(5): 529 - 534.
[Abstract] [Full Text]


Home page
CirculationHome page
K. Vikenes, M. Farstad, and J. E. Nordrehaug
Serotonin Is Associated with Coronary Artery Disease and Cardiac Events
Circulation, August 3, 1999; 100(5): 483 - 489.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. Ikeda, T. Ueyama, T. Murohara, H. Yasukawa, N. Haramaki, H. Eguchi, A. Katoh, Y. Takajo, I. Onitsuka, T. Ueno, et al.
Adhesive Interaction Between P-Selectin and Sialyl Lewisx Plays an Important Role in Recurrent Coronary Arterial Thrombosis in Dogs
Arterioscler Thromb Vasc Biol, April 1, 1999; 19(4): 1083 - 1090.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. D. Folts, A. I. Schafer, J. Loscalzo, J. T. Willerson, and J. E. Muller
A perspective on the potential problems with aspirin as an antithrombotic agent: a comparison of studies in an animal model with clinical trials
J. Am. Coll. Cardiol., February 1, 1999; 33(2): 295 - 303.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Katoh, H. Ikeda, T. Murohara, N. Haramaki, H. Ito, and T. Imaizumi
Platelet-Derived 12-Hydroxyeicosatetraenoic Acid Plays an Important Role in Mediating Canine Coronary Thrombosis by Regulating Platelet Glycoprotein IIb/IIIa Activation
Circulation, December 22, 1998; 98(25): 2891 - 2898.
[Abstract] [Full Text] [PDF]


Home page
Arch Gen PsychiatryHome page
D. L. Musselman, D. L. Evans, and C. B. Nemeroff
The Relationship of Depression to Cardiovascular Disease: Epidemiology, Biology, and Treatment
Arch Gen Psychiatry, July 1, 1998; 55(7): 580 - 592.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
T. Ueyama, H. Ikeda, N. Haramaki, K. Kuwano, and T. Imaizumi
Effects of Monoclonal Antibody to P-Selectin and Analogue of Sialyl Lewis X on Cyclic Flow Variations in Stenosed and Endothelium-Injured Canine Coronary Arteries
Circulation, March 18, 1997; 95(6): 1554 - 1559.
[Abstract] [Full Text]


Home page
J. Pharmacol. Exp. Ther.Home page
J.-P. Valentin, S. Vieu, F. Bertolino, P. Fauré, and G. W. John
Differential Involvement of Serotonin 2A/C and Thromboxane A2/Prostanoid Receptors in High- vs. Low-Shear Rate Arterial Thrombosis in Rabbits
J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 761 - 769.
[Abstract] [Full Text]


Home page
CirculationHome page
J. T. Willerson
Inhibitors of Platelet Glycoprotein IIb/IIIa Receptors: Will They Be Useful When Given Chronically?
Circulation, September 1, 1996; 94(5): 866 - 868.
[Full Text]


Home page
CirculationHome page
N. Maalej and J. D. Folts
Increased Shear Stress Overcomes the Antithrombotic Platelet Inhibitory Effect of Aspirin in Stenosed Dog Coronary Arteries
Circulation, March 15, 1996; 93(6): 1201 - 1205.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
G. S. O'Neil, A. H. Chester, C. J. Schyns, S. Tadjkarimi, J. A. A. Borland, and M. H. Yacoub
Effect of surgical preparation and arterialization on vasomotion of human saphenous vein
J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 699 - 706.
[Abstract] [Full Text]


Home page
NEJMHome page
P. Golino, F. Piscione, C. R. Benedict, H. V. Anderson, M. Cappelli-Bigazzi, C. Indolfi, M. Condorelli, M. Chiariello, and J. T. Willerson
Local Effect of Serotonin Released during Coronary Angioplasty
N. Engl. J. Med., February 24, 1994; 330(8): 523 - 528.
[Abstract] [Full Text]